| Announcement Title |
Intermediate Securities Distribution |
| Date & Time of Broadcast |
Oct 31, 2018 19:45 |
| Status |
Replace |
| Corporate Action Reference |
SG181030RHDIRPA7 |
| Submitted By (Co./ Ind. Name) |
Simon Garing |
| Designation |
Executive Director and Chief Executive Officer |
| Event Status |
Pending AIP/ LQN Announcement |
| Underwritten |
Yes |
| Shareholders' Approval Required? |
Yes |
| Shareholders' Approval Obtained |
No |
| Financial Year End |
31/12/2018 |
| Foreign Shareholder Eligibility |
No |
| Rights Issue Announcement 30 October 2018.pdf |
| Acquisition Announcement 30 October 2018.pdf |
| Issue and Despatch of Circular.pdf |
|
| Regulatory Outcome |
| Attachment For Regulatory Outcome |
|
| Rights Issue Announcement 30 October 2018_final.pdf |
| Event Narrative |
| Narrative Type |
Narrative Text |
| Additional Text |
Please see attached the following announcement: 1. Acquisitions and Proposed Rights issue. |
| Additional Text |
Sponsorhip Statement: Goldman Sachs (Singapore) Pte. and UBS AG, Singapore Branch were the joint issue managers for the initial public offering of CEREIT. DBS Bank Ltd., Goldman Sachs (Singapore) Pte., and UBS AG, Singapore Branch were the joint global coordinators for the initial public offering of CEREIT. |
| Additional Text |
DBS Bank Ltd., Goldman Sachs (Singapore) Pte., UBS AG, Singapore Branch, Daiwa Capital Markets Singapore Limited and CLSA Singapore Pte Ltd were the joint bookrunners and underwriters for the initial public offering of CEREIT. |
| Dates |
| Rights Details |
| Security Not Found? |
Yes |
| Renounceable |
Yes |
| Rights Security Distribution Ratio- Underlying |
100 |
| Rights Security Distribution Ratio- Rights Security |
38 |
| |
| Option Exercise |
| Issue Price (Per Rights) |
EUR 0.373 |
| Disbursed Security |
| ISIN |
Name |
Security Type |
Distribution Ratio- Rights |
Distribution Ratio- Disbursed |
| SG1EA8000000 |
CROMWELL EUROPEAN REIT |
Units Trusts |
1 |
1 |
|
| Note- Any information entered in narrative will not be used in processing |
| Narrative Type |
Narrative Text |
|
| Renounceable Conditions |
| Narrative Type |
Narrative Text |
| |
|
|
| Allow Over Subscription |
Yes |
